Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
European Journal of Cancer (Oxford, England : 1990)|October 2, 2009
Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study)Alberto Fusi, Sandra Collette, Antonia Busse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 27, 2013
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancerRadosław Polański, Cassandra L Hodgkinson, Alberto Fusi, et al.
Cancer Immunology, Immunotherapy : CII|April 30, 2013
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study)Antonia Busse, Jérôme Rapion, Alberto Fusi, et al.
Cancer Discovery|December 31, 2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria Romina Girotti, Gabriela Gremel, Rebecca Lee, et al.
Melanoma Research|July 31, 2015
Ipilimumab in the real world: the UK expanded access programme experience in previously treated advanced melanoma patientsSaif S Ahmad, Wendi Qian, Sarah Ellis, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2023
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM)Alimu Dayimu, Avinash Gupta, Rubeta N Matin, et al.
Cancer Cell|December 16, 2014
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanomaMaria Romina Girotti, Filipa Lopes, Natasha Preece, et al.
Nature Communications|November 10, 2016
Vasculogenic mimicry in small cell lung cancerStuart C Williamson, Robert L Metcalf, Francesca Trapani, et al.
Nature Communications|February 11, 2017
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitorsMoritz Schütte, Thomas Risch, Nilofar Abdavi-Azar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.
Pageof 8